Fiduciary Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $213K | Buy |
2,961
+299
| +11% | +$23K | 0.02% | 287 |
|
|
2025
Q4 | $211K | Hold |
2,662
| – | – | 0.02% | 284 |
|
|
2025
Q3 | $201K | Buy |
+2,662
| New | +$182K | 0.02% | 284 |
|
|
2024
Q4 | – | Sell |
-3,989
| Closed | -$251K | – | 273 |
|
|
2024
Q3 | $251K | Sell |
3,989
-2,051
| -34% | -$120K | 0.03% | 249 |
|
|
2024
Q2 | $357K | Sell |
6,040
-985
| -14% | -$61.6K | 0.04% | 216 |
|
|
2024
Q1 | $560K | Sell |
7,025
-332
| -5% | -$25.4K | 0.06% | 175 |
|
|
2023
Q4 | $581K | Sell |
7,357
-49,931
| -87% | -$3.55M | 0.07% | 163 |
|
|
2023
Q3 | $4M | Sell |
57,288
-81
| -0.1% | -$5.74K | 0.51% | 52 |
|
|
2023
Q2 | $3.97M | Buy |
57,369
+1,002
| +2% | +$71.3K | 0.49% | 55 |
|
|
2023
Q1 | $4.19M | Buy |
56,367
+422
| +0.8% | +$35.4K | 0.54% | 49 |
|
|
2022
Q4 | $5.21M | Sell |
55,945
-785
| -1% | -$75.7K | 0.69% | 44 |
|
|
2022
Q3 | $5.67M | Buy |
56,730
+3,738
| +7% | +$370K | 0.73% | 42 |
|
|
2022
Q2 | $5.52M | Buy |
52,992
+13,000
| +33% | +$1.27M | 0.69% | 43 |
|
|
2022
Q1 | $3.92M | Buy |
39,992
+33,022
| +474% | +$3.47M | 0.52% | 52 |
|
|
2021
Q4 | $719K | Buy |
6,970
+1,643
| +31% | +$152K | 0.08% | 137 |
|
|
2021
Q3 | $470K | Hold |
5,327
| – | – | 0.05% | 158 |
|
|
2021
Q2 | $434K | Hold |
5,327
| – | – | 0.05% | 165 |
|
|
2021
Q1 | $407K | Buy |
5,327
+1,265
| +31% | +$92.1K | 0.05% | 164 |
|
|
2020
Q4 | $299K | Buy |
4,062
+100
| +3% | +$6.5K | 0.04% | 178 |
|
|
2020
Q3 | $231K | Buy |
3,962
+12
| +0.3% | +$747 | 0.03% | 184 |
|
|
2020
Q2 | $257K | Buy |
3,950
+200
| +5% | +$12.6K | 0.04% | 174 |
|
|
2020
Q1 | $222K | Buy |
3,750
+200
| +6% | +$13.4K | 0.04% | 159 |
|
|
2019
Q4 | $264K | Sell |
3,550
-3,035
| -46% | -$213K | 0.04% | 170 |
|
|
2019
Q3 | $415K | Buy |
6,585
+100
| +2% | +$5.93K | 0.07% | 143 |
|
|
2019
Q2 | $353K | Buy |
6,485
+200
| +3% | +$10.8K | 0.06% | 147 |
|
|
2019
Q1 | $339K | Buy |
6,285
+813
| +15% | +$50.2K | 0.06% | 145 |
|
|
2018
Q4 | $359K | Buy |
+5,472
| New | +$408K | 0.07% | 138 |
|
|
2017
Q1 | – | Sell |
-7,327
| Closed | -$578K | – | 178 |
|
|
2016
Q4 | $578K | Sell |
7,327
-2,677
| -27% | -$217K | 0.15% | 113 |
|
|
2016
Q3 | $890K | Sell |
10,004
-311
| -3% | -$29.4K | 0.24% | 85 |
|
|
2016
Q2 | $988K | Sell |
10,315
-1,935
| -16% | -$193K | 0.27% | 82 |
|
|
2016
Q1 | $1.27M | Sell |
12,250
-2,560
| -17% | -$249K | 0.37% | 70 |
|
|
2015
Q4 | $1.45M | Sell |
14,810
-6,719
| -31% | -$658K | 0.43% | 68 |
|
|
2015
Q3 | $2.08M | Buy |
21,529
+2,430
| +13% | +$255K | 0.69% | 51 |
|
|
2015
Q2 | $2M | Buy |
+19,099
| New | +$1.95M | 0.63% | 50 |
|
Other funds holding CVS
VCM
VPM
Fiduciary Group's CVS Position: Q1 2026 in Review
Fiduciary Group increased its CVS Health (CVS) stake by 11% in Q1 2026, buying an estimated $23K and bringing the position to 2,961 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #287.
Fiduciary Group first reported a position in CVS in Q2 2015 and has held it in 34 quarters since. The position peaked at $5.67M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Fiduciary Group held 2,961 shares of CVS Health worth $213K as of Q1 2026.
- Fiduciary Group bought 299 CVS Health shares in Q1 2026, an estimated $23K.
- CVS Health made up 0.02% of Fiduciary Group's portfolio in Q1 2026, its #287 holding.
- Fiduciary Group first reported a position in CVS Health in Q2 2015 and has held it in 34 quarters since.
- Fiduciary Group's CVS Health position peaked at $5.67M in Q3 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.